ArticlePharmacoEconomics - open2026

Threshold Price of Belantamab for Relapsed/Refractory Multiple Myeloma in China: A Cost-Effectiveness Analysis.

Xiaotong Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.